K L Nathanson
Overview
Explore the profile of K L Nathanson including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
35
Citations
1199
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Rowlands C, Allen S, Balmana J, Domchek S, Evans D, Hanson H, et al.
Ann Oncol
. 2024 Jul;
35(10):892-901.
PMID: 38986768
Background: Germline genetic testing, previously restricted to familial and young-onset breast cancer, is now offered increasingly broadly to patients with 'population-type' breast cancer in mainstream oncology clinics, with wide variation...
2.
Fishbein L, Ben-Maimon S, Keefe S, Cengel K, Pryma D, Loaiza-Bonilla A, et al.
Endocr Relat Cancer
. 2017 Jun;
24(8):L51-L55.
PMID: 28566531
No abstract available.
3.
Scelo G, Hofmann J, Banks R, Bigot P, Bhatt R, Cancel-Tassin G, et al.
Ann Oncol
. 2016 May;
27(8):1382-5.
PMID: 27130845
Recent years have seen important advances in our understanding of the etiology, biology and genetics of kidney cancer. To summarize important achievements and identify prominent research questions that remain, a...
4.
Sargen M, Merrill S, Chu E, Nathanson K
Br J Dermatol
. 2016 Feb;
175(4):785-9.
PMID: 26876133
An inherited germline mutation in CDKN2A is the most common cause of familial atypical multiple mole melanoma (FAMMM) syndrome. Although it is well known that CDKN2A mutations confer an increased...
5.
Vultur A, Villanueva J, Krepler C, Rajan G, Chen Q, Xiao M, et al.
Oncogene
. 2013 Apr;
33(14):1850-61.
PMID: 23624919
Elevated activity of the mitogen-activated protein kinase (MAPK) signaling cascade is found in the majority of human melanomas and is known to regulate proliferation, survival and invasion. Current targeted therapies...
6.
Kumar S, Dai J, Li S, Yang R, Yu H, Nathanson K, et al.
Oncogene
. 2013 Jan;
33(7):832-41.
PMID: 23334329
Adult stem cells are multipotent and persist in small numbers in adult tissues throughout the lifespan of an organism. Unlike differentiated cells, adult stem cells are intrinsically resistant to senescence....
7.
Jakubowska A, Rozkrut D, Antoniou A, Hamann U, Scott R, McGuffog L, et al.
Br J Cancer
. 2012 Jun;
106(12):2016-24.
PMID: 22669161
Background: The variable penetrance of breast cancer in BRCA1/2 mutation carriers suggests that other genetic or environmental factors modify breast cancer risk. Two genes of special interest are prohibitin (PHB)...
8.
Fishbein L, Bonner L, Torigian D, Nathanson K, Cohen D, Pryma D, et al.
Horm Metab Res
. 2012 May;
44(5):405-10.
PMID: 22566196
In patients with malignant pheochromocytoma and paraganglioma, 131I-MIBG radiotherapy can achieve an objective response rate of 30-50% with the dose limiting toxicity being hematologic. Patients with disseminated disease, who also...
9.
Cohen J, Chiel L, Boghossian L, Jones M, Stopfer J, Powers J, et al.
Fam Cancer
. 2011 Sep;
11(1):69-75.
PMID: 21898151
Risk-reducing salpingo-oophorectomy (RRSO) significantly reduces the risk of ovarian cancer and breast cancer in pre-menopausal women with BRCA1 and BRCA2 (B1/2) mutations. Despite its clear benefits, little is known about...
10.
Osorio A, Milne R, Alonso R, Pita G, Peterlongo P, Teule A, et al.
Br J Cancer
. 2011 Mar;
104(8):1356-61.
PMID: 21427728
Background: Single-nucleotide polymorphisms (SNPs) in genes involved in DNA repair are good candidates to be tested as phenotypic modifiers for carriers of mutations in the high-risk susceptibility genes BRCA1 and...